IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PILOTTO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.456
AS - Asia 6.457
EU - Europa 4.155
SA - Sud America 1.452
Continente sconosciuto - Info sul continente non disponibili 308
AF - Africa 156
OC - Oceania 11
Totale 23.995
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.073
SG - Singapore 2.415
CN - Cina 1.654
BR - Brasile 1.204
IT - Italia 1.133
HK - Hong Kong 725
DE - Germania 582
BD - Bangladesh 518
FR - Francia 512
VN - Vietnam 430
UA - Ucraina 412
GB - Regno Unito 328
FI - Finlandia 306
RU - Federazione Russa 218
CA - Canada 216
TR - Turchia 196
IE - Irlanda 172
IN - India 150
NL - Olanda 88
MX - Messico 87
AR - Argentina 85
PL - Polonia 82
ES - Italia 66
CZ - Repubblica Ceca 58
JP - Giappone 53
ZA - Sudafrica 53
SE - Svezia 52
ID - Indonesia 51
AT - Austria 50
IQ - Iraq 47
EC - Ecuador 36
CO - Colombia 35
SA - Arabia Saudita 31
VE - Venezuela 28
PK - Pakistan 25
MA - Marocco 22
BE - Belgio 20
EG - Egitto 20
UZ - Uzbekistan 17
CL - Cile 16
JM - Giamaica 16
KE - Kenya 16
PY - Paraguay 15
AE - Emirati Arabi Uniti 14
CR - Costa Rica 13
JO - Giordania 13
LT - Lituania 13
PH - Filippine 13
AZ - Azerbaigian 11
KZ - Kazakistan 11
NP - Nepal 11
IL - Israele 10
PE - Perù 10
AU - Australia 9
BO - Bolivia 9
NG - Nigeria 9
PT - Portogallo 9
UY - Uruguay 9
CH - Svizzera 8
GT - Guatemala 8
MY - Malesia 8
PA - Panama 8
AL - Albania 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
LB - Libano 7
TH - Thailandia 7
IR - Iran 6
RO - Romania 6
SN - Senegal 6
ET - Etiopia 5
OM - Oman 5
PS - Palestinian Territory 5
TN - Tunisia 5
TW - Taiwan 5
BB - Barbados 4
EU - Europa 4
GE - Georgia 4
GY - Guiana 4
LV - Lettonia 4
RS - Serbia 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
BY - Bielorussia 3
DK - Danimarca 3
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
KR - Corea 3
MD - Moldavia 3
NI - Nicaragua 3
PR - Porto Rico 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
BN - Brunei Darussalam 2
BS - Bahamas 2
CG - Congo 2
CI - Costa d'Avorio 2
DM - Dominica 2
Totale 23.662
Salva come PNG Salva come JPEG
Città #
Singapore 1.297
Ashburn 1.280
Fairfield 884
Hong Kong 721
Woodbridge 576
San Jose 543
New York 471
Houston 418
Los Angeles 408
Seattle 401
The Dalles 372
Beijing 342
Cambridge 328
Jacksonville 322
Dallas 312
Wilmington 299
Ann Arbor 262
Princeton 237
Helsinki 205
Lauterbourg 193
Chandler 189
Milan 180
Istanbul 170
Chicago 160
Ho Chi Minh City 154
Dublin 153
Munich 151
Buffalo 145
Santa Clara 132
Columbus 121
Council Bluffs 116
San Francisco 111
Des Moines 101
São Paulo 100
Brescia 99
Dearborn 97
Nanjing 94
Redondo Beach 88
Hanoi 86
London 81
Warsaw 79
Denver 77
Montreal 77
San Diego 75
Orem 74
Moscow 73
Rome 68
Atlanta 67
Nuremberg 62
Brooklyn 59
Toronto 59
Turku 57
Shanghai 55
Frankfurt am Main 53
Shenyang 50
Chennai 49
Phoenix 48
Salt Lake City 45
Boston 44
Changsha 44
Tokyo 40
Guangzhou 38
Nanchang 37
Rio de Janeiro 34
Stockholm 34
Brno 33
Mexico City 32
Belo Horizonte 31
Tampa 30
Boardman 29
Lappeenranta 29
Naples 29
Lancaster 28
Jinan 26
Tianjin 26
Vienna 26
Madrid 25
Manchester 25
Johannesburg 24
Hangzhou 23
Ningbo 23
Amsterdam 22
Brasília 22
Da Nang 22
Charlotte 21
Hebei 21
Romola 21
Olomouc 20
Verona 20
Zhengzhou 20
Elk Grove Village 19
Florence 19
Norwalk 19
Brussels 18
Dhaka 18
Poplar 18
Guarulhos 17
Turin 17
Düsseldorf 16
Kunming 16
Totale 14.602
Salva come PNG Salva come JPEG
Nome #
Functional outcome improvement from 3 to 12 months after intracerebral hemorrhage 1.718
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 357
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 352
COVID-19 impact on consecutive neurological patients admitted to the emergency department 266
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease 232
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 226
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 224
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 210
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation 199
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease 195
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases 192
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 188
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 188
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 187
Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer’s Disease: A Case Control Study 180
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 178
Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts 177
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 172
FOXP2, APOE, and PRNP: new modulators in primary progressive aphasia. 169
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 169
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study 169
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. 167
Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension 163
Vascular risk factors and cognition in Parkinson's disease 161
Association of Antidementia Drugs and Mortality in Community-Dwelling Frail Older Patients With Dementia: The Role of Mortality Risk Assessment 160
Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease 159
A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short- and long-term all-cause mortality in older hospitalized patients with transient ischemic attack 158
Microarray gene and miRNA expression studies: Looking for new therapeutic targets for frontotemporal lobar degeneration 157
Clinical, biological, and imaging features of monogenic Alzheimer's Disease. 154
Association between cognitive impairment and urinary dysfunction in Parkinson’s disease 153
Three Decades of Comprehensive Geriatric Assessment: Evidence Coming From Different Healthcare Settings and Specific Clinical Conditions 151
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 149
Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders 147
Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria 147
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease 144
Unveiling New Genetic Variants Associated with Age at Onset in Alzheimer's Disease and Frontotemporal Lobar Degeneration Due to C9orf72 Repeat Expansions 141
Warfarin Treatment and All-Cause Mortality in Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study 138
Reply to the Letter " Covid-19-associated encephalopathy and cytokine-mediated Neuroinflammation" 137
Central serous chorioretinopathy: Pathogenesis and management 136
Metal Exposure and SNCA rs356219 Polymorphism Associated With Parkinson Disease and Parkinsonism 136
Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study. 135
Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs 135
Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles 134
Overlap between frontotemporal dementia and alzheimer's disease: Cerebrospinal fluid pattern and neuroimaging study 134
TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia. 133
Steroid-Responsive Encephalitis in Coronavirus Disease 2019 133
Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life. 132
Functional genetic variation in the serotonin 5-HTTLPR modulates brain damage in frontotemporal dementia. 132
Verbal memory declines more in female patients with Parkinson's disease: The importance of gender-corrected normative data 132
Autonomic dysfunction in subjects at high risk for Parkinson’s disease 131
GBA-associated parkinsonism and dementia: Beyond α-synucleinopathies? 131
Long-term neurological outcome in patients presenting with encephalitis 131
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 129
Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA 129
Dopaminergic deficits along the spectrum of Alzheimer’s disease 128
Disease-modifying therapies in frontotemporal lobar degeneration. 127
Erratum: Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases (Neuron (2016) 91(1) (56–66)(S0896627316301970)(10.1016/j.neuron.2016.05.018)) 127
Pharmacogenetics of cytochrome P450 (CYP) in the elderly 124
Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson’s disease 124
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 124
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 123
Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findings 123
Developments in the Role of Transcranial Sonography for the Differential Diagnosis of Parkinsonism 122
Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study. 121
In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody 121
Impulse control disorder in PD: A lateralized monoaminergic frontostriatal disconnection syndrome? 120
Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study 119
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET 119
The p.Val234Met LRP10 likely pathogenic variant associated with Parkinson's disease: Possible molecular implications 118
Family History in Parkinson's Disease: A National Cross-Sectional Study 117
Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with parkinson's disease 116
Third ventricular width assessed by transcranial ultrasound correlates with cognitive performance in Parkinson's disease 116
Plasma neurofilament light chain predicts cognitive progression in prodromal and clinical dementia with lewy bodies 116
Brain glucose metabolism in Lewy body dementia: Implications for diagnostic criteria 114
Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study 114
Association of hippocampal subfields, CSF biomarkers and cognition in non-demented Parkinson's disease patients 114
Plasma Cystatin C correlates with plasma NfL levels and predicts disease progression in Parkinson's disease 114
Effects of dopaminergic treatment on inhibitory control differ across Hoehn and Yahr stages of Parkinson's disease 113
Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19 113
Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection 112
The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infection 111
Metabolic patterns across core features in dementia with lewy bodies 111
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 111
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 111
Brain-area specific white matter hyperintensities: Associations to falls in Parkinson's disease 110
NF-κB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients 109
Long-term neurological manifestations of COVID-19: prevalence and predictive factors 109
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 108
Biofluid Markers and Tissue Biopsies Analyses for the Prodromal and Earliest Phase of Parkinson's Disease 107
Impaired metabolic brain networks associated with neurotransmission systems in the α-synuclein spectrum 107
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19 106
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease 104
Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study 102
Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves 102
Occipital atrophy signature in prodromal Lewy bodies disease 100
Effects of COVID-19 outbreak on stroke admissions in Brescia, Lombardy, Italy 100
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 99
Struktureller Ultraschall des medialen Temporallappens bei Alzheimer-Demenz 99
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 99
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 98
Totale 15.859
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.977
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022894 0 120 36 54 35 57 45 76 58 90 83 240
2022/2023794 135 23 9 27 74 216 12 63 115 16 54 50
2023/20241.220 80 20 105 61 58 231 47 42 295 23 48 210
2024/20254.065 56 26 47 515 394 261 264 177 488 393 945 499
2025/20269.392 794 1.114 724 1.234 720 631 1.267 505 597 769 634 403
2026/20272.312 2.070 242 0 0 0 0 0 0 0 0 0 0
Totale 23.995